Adjunctive and novel therapies for sepsis.
Primary goals of sepsis therapy include early, appropriate antimicrobial therapy and prompt recognition and reversal of shock. Despite these measures, however, sepsis remains an important source of pediatric morbidity and mortality. Here we review rationale and existing evidence in support of adjunctive sepsis therapies including extracorporeal support, immunomodulation, and mitochondria-targeted therapies. While each of these therapeutic modalities shows promise, additional studies are urgently needed to identify the right patients, the right timing, and the right context for these interventions.
['Muszynski|Jennifer A|JA|', 'Frazier|W Joshua|WJ|', 'Hall|Mark W|MW|']
Sepsis immunomodulation extra corporeal membrane oxygenation mitochondria renal dialysis